Recently, B. Braun Medical and Borns Medical Robotics announced a major strategic partnership to break through the development barriers of the robotic surgery market and jointly promote the standardized application of robotic surgery. Under the terms of the new agreement, the two companies will advance robotic surgery with standardized surgical consumables, surgical training, marketing and international product strategy.

▲Mr.Su Jin, President of B.Braun Greater China, and Dr. Li Yao, founder of Borns, co-chaired the signing ceremony

B. Braun, a leading manufacturer of medical devices, and Borns, a leader in the development of robotic surgical technology, began collaborating in 2018.With the integration of minimally invasive surgical devices and advanced medical imaging technology, several major breakthroughs have been achieved. The two sides are committed to developing a new surgical platform comprised of a standardized, automated and intelligent robotic surgery system. At the same time establishing the pathway for system training, system certification and application demonstration, thereby creating a new concept of minimally invasive surgery in the exploration of design, manufacturing, and international clinical practice.

01

Standardized Robotic Surgery

The Borns Surgical Robotic System series robotic system, fully equipped with B.Braun(Aesculap) surgical instruments and the Einstein 3D laparoscopic system, has implemented next generation functionality in endoscopic surgery. The Borns Surgical Robotic System has successfully participated in a number of clinical trials in Max Healthcare Hospital, India. The B.Braun and Borns alliance will further promote the standardization of robotic surgery, thus changing the global surgical landscape benefitting patients world-wide.

Robotic surgery will be at the forefront of continuously improving surgical outcomes in the future.Mr.Su Jin, President of B.Braun Greater China, said,"B.Braun actively promotes the standardized application of surgical robots, and is committed to realizing the corporate vision of protecting and improving the health of people around the world.”

▲Mr.Su Jin (R), President of B.Braun Greater China, and Dr. Alexander Teichmann, Chief Medical Director, Bosch

Dr. Alexander Teichmann, Borns Chief Medical Director, said, " We have been constantly advancing robotic surgery to better serve patients by advancing standardized applications. The success of the international multicenter is a good start, and we look forward to a better future.”

02

Systemized Surgical Training

Committed to global multicenter clinical research, Borns has carried out a series of international robotic surgery training programs. Successful training continues in the United States, Australia, Germany, the Netherlands, Israel, Britain, France, Italy, the United Arab Emirates and other countries and regions. For the upcoming clinical research in Germany and China, Mr Chen, dean of the academy of snake said the two sides will conduct standardized training and practice courses, and comprehensive use of the Borns surgery in (ERAS) and (Daily Surgery) ultimately displaying the advantages of standardized robot surgery.

03

Diversified Market Promotion

The strategic partnership between B. Braun and Borns brings together their respective resources and expedites the promotion of Borns robotic products. Ms.Deng Haiqiong, Vice President of Sales and Marketing of B.Braun Aesculap Brand Division, said, " Both sides should accelerate the bottleneck of clinical popularization of robots by establishing the standard of clinical application of minimally invasive surgical robots in China.”

04

International Product Strategy

Through this strategic partnership the quality of patient treatment will be markedly improved, the standard of surgery will be enhanced, and new heights of robotic surgical technology will be continuously explored. Dr. Li Yao, president of Borns, said the company is committed to bringing more value to medical services, and will work with B.Braun to promote the standardized application of robotic surgery and jointly develop a new blueprint in the field of intelligent surgery.

Dr. Isabela Scheibner, Mr.Pedro Morales (fourth from left), senior director of R & D and Innovation Project of Beran Group, and Dr. Dr. Isabela Scheibner, chief clinical surgeon of Europe, discussed international multi-center research

The B. Braun and Borns strategic alliance will standardize the development of robotic surgical design, research and development, production, and training with the goal of promoting laparoscopic surgery in the robotic era.Focusing on minimally invasive surgery solutions, patients receive safe and effective outcomes, resulting in repeatable clinical efficiency in hospitals around the world.